USPTO serial 97375044
TWINE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- GINSBERG, MICHAEL
- Law office
- TMEG LAW OFFICE 105 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with TWINE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Maury M. Tepper, III
Maury M. Tepper, III TEPPER & EYSTER, PLLC3724 BENSON DRRALEIGH, NC 27609-7321UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer software used for data processing; Downloadable computer application software for data processing; downloadable computer software for data processing; electronic apparatus and electronic equipment , namely, computer hardware and computer peripherals, downloadable software, downloadable computer programs and systems comprised of computer hardware and computer peripherals, all for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and/or transmission of data, images and information; mechanisms for data processing equipment, namely, data processors and computers, computers; data sets, recorded or downloadable, in the field of medical research data, patient medical information and clinical trial data; electronic apparatus and electronic equipment, namely, computer hardware and computer peripherals, downloadable software, downloadable computer programs and systems comprised of computer hardware and computer peripherals, all for the conversion, analysis, processing, storage and transmission of artificial intelligence data; artificial intelligence and machine learning software for statistical analysis, consultancy and reporting; software for analytics in the fields of public health, healthcare, pharmaceuticals, biotechnology, biomedical research and development, clinical trials; computer software for database integration; computer software for creating searchable databases of information and data; computer software featuring electronic computer databases of medical research data, clinical trials data, patient information and medical industry stakeholders information; computer software for accessing data and information related to patient medical information, medical research data and clinical trial data and for controlling and managing data and information related to medical research data, patient medical information and clinical trial data; computer software platforms for integrating clinical and non-clinical patient and medical data; computer software to enable sharing of data and comments among users; data communication apparatus that transmit data and information to databases; downloadable software in the nature of mobile applications; all the aforesaid goods to be used in the medical and healthcare fields | ACTIVE | — |
| 035 | Collection, systematization, compilation and analysis of business data and information into computer databases; business analysis and consultancy and statistical analysis of healthcare data, biomedical research and clinical trial data for business purposes; database management; compilation of information into computer databases in the fields of medical research, public health, healthcare, biomedicine, biotechnology, pharmaceuticals, clinical trials, pharmacoepidemiologic research and evaluating outcomes; professional business analysis and consultancy and statistical analysis in the fields of medical research, public health, healthcare, pharmaceuticals, biotechnology, biomedical research and developments, clinical trials, pharmacoepidemiologic research and research evaluating outcomes; business consulting and management in the field medical research, namely, management and compilation of computerized databases in the field of medical research data and clinical trials for business purposes; data search in computer files for others; registration of written communications and data; updating and maintenance of data in computer databases; all the aforesaid services to be provided in the medical and healthcare fields | ACTIVE | — |
| 038 | Telecommunications, namely, electronic data transmission, electrical and electronic communications, namely electronic data transmission; providing access to databases; transmission of data; all the aforesaid services to be provided in the medical and healthcare fields | ACTIVE | — |
| 042 | Software as a Service (SAAS) services featuring software for collecting and analyzing medical and healthcare data; platform as a service featuring computer software platforms for accessing database with information, data, statistics, insights, metrics, profiles, analytics and intelligence on public health, healthcare, biomedicine, pharmaceuticals, clinical trials, pharmacoepidemiologic research and evaluating outcomes; cloud computing featuring software for use in extracting, analyzing, standardizing and cleaning clinical, medical and healthcare data; providing a website featuring technology that enables users to share and process data for use in the fields of scientific research, medical and healthcare fields; a computerized knowledge exchange website featuring technology that enables exchanging and analyzing of medical, scientific and clinical trial information by users, including segregated, dispersed or disparate data, which uses big data analytics, machine learning and natural language processing; database design and development; bioinformatics interpretation of health data; compiling data for research purposes in the field of medical science and medical consultancy; design, development, installation, upgrading and maintenance of computer software; design of information graphics and data visualization materials for use in the medical and healthcare fields.; providing temporary use of online non-downloadable cloud-based software for data collection, data research, data management, and data analysis in the medical and healthcare fields; providing computer software for use in medical and healthcare fields; providing computer application software for use in medical and healthcare fields; data conversion of electronic information; providing temporary use of non-downloadable software regarding analytics in the fields of medical research, public health, healthcare, biomedicine, biotechnology, pharmaceuticals, clinical trials, pharmacoepidemiologic research data; providing temporary use of software for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and/or transmission of data, images and information of health data; scientific data processing analysis services; providing temporary use of non-downloadable software to enable sharing of data and comments among users; scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; electronic data storage; testing, inspection and research of pharmaceuticals and providing advice and information thereof; all the aforesaid services to be provided in the medical and healthcare fields | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 9, 2024 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jan 9, 2024 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jan 9, 2024 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Sep 21, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 21, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 21, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 18, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 16, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 16, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| May 13, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 12, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 12, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 25, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 25, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 25, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 8, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 27, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 25, 2022 | NWAP | NEW APPLICATION ENTERED | — |